AirXpanders, Inc. Reports 100% Treatment Success in PACE Trial for Post-Mastectomy Breast Reconstruction Patients
3/4/2013 9:46:31 AM
More...
|
AirXpanders, Inc. Announces Preliminary Results From Two Clinical Studies That Show Breast Reconstruction Patients Completed Tissue Expansion With AeroForm™ Patient-Controlled Tissue Expander in 17 Days on Average
11/6/2012 7:29:39 AM
More...
|
AirXpanders, Inc. Breast Tissue Expansion System Gets CE Mark Approval
10/31/2012 7:01:16 AM
More...
|
AirXpanders, Inc. Release: Baptist South Medical Center Enrolling Patients in Study of New Tissue Expansion Method for Women Undergoing Breast Reconstruction after Mastectomy
7/23/2012 9:45:32 AM
More...
|
AirXpanders, Inc. Announces Completion of Enrollment of PACE Study Supporting Use of AeroForm(TM) Patient Controlled Tissue Expander for Breast Reconstruction
6/7/2012 9:22:17 AM
More...
|
AirXpanders, Inc. Announces Expansion of Leadership Team
4/17/2012 11:40:06 AM
More...
|
AirXpanders, Inc. Secures $10 Million in Series D Financing
1/23/2012 9:00:38 AM
More...
|
AirXpanders, Inc. Announces First Patient Treated in IDE Trial of New Post-Mastectomy Tissue Expansion Device
12/5/2011 11:17:26 AM
More...
|
AirXpanders, Inc. Announces Publication of Study Results Supporting the Use of the AeroForm(TM) Patient Controlled Breast Tissue Expander
9/22/2011 9:10:09 AM
More...
|
FDA Grants AirXpanders, Inc. an Investigational Device Exemption to Begin Pivotal Study of an Investigational Tissue Expansion System for Women Undergoing Breast Reconstruction After Mastectomy
8/29/2011 9:00:17 AM
More...
|
|